Insight into Stenotrophomonas maltophilia Infections in a Tertiary Care Teaching Hospital in Western India and Review of Literature: A Retrospective Observational Study

被引:1
作者
Bacchani, Daisy [1 ]
Rajni, Ekadashi [1 ,3 ]
Kataria, Shaveta [1 ]
Sharma, Chinkle [1 ]
Sharma, Richa [1 ]
Garg, Vishnu Kumar [2 ]
机构
[1] All India Inst Med Sci, Dept Microbiol, Jodhpur, Rajasthan, India
[2] Mahatma Gandhi Univ Med Sci & Technol, Dept Anaesthesia, Jaipur, Rajasthan, India
[3] Mahatma Gandhi Univ Med Sci & Technol, Dept Microbiol, Jaipur 302022, Rajasthan, India
关键词
Bacteraemia; Co-trimoxazole; Non fermenter; Opportunistic pathogen; PNEUMONIA; COMMUNITY;
D O I
10.7860/JCDR/2024/67105.19160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Stenotrophomonas maltophilia (S. maltophilia) is a ubiquitous and opportunistic pathogen of growing importance. This gram -negative, non fermenter is widely distributed in moist hospital environments. It is intrinsically resistant to a number of antibiotics, making it a challenge both for the clinician and the microbiologist. Very sparse data is available from Western India regarding this emerging pathogen. Aim: To determine the prevalence and spectrum of infections caused by S. maltophilia and to provide an overview of associated co -morbidities, antibiotic susceptibility pattern of these isolates, and clinical outcomes. Materials and Methods: This retrospective observational study was carried out in a tertiary care private hospital (Mahatma Gandhi Hospital) in Jaipur, Rajasthan, India over a period of one year (July 2021 -June 2022). A total of 11,170 samples were received in the microbiology laboratory for bacterial culture and susceptibility testing during the study period and processed as per standard protocols. Only one isolate per patient was included for the purpose of the study. Culture identification and antibiotic susceptibility testing was done using the VITEK-2 automated system. Data regarding patients' demographic profile, epidemiological profile, baseline characteristics, comorbidities, laboratory findings, and clinical outcome were tabulated in an Excel worksheet and analysed. All statistical analysis was done using the Software Statistical Package for the Social Sciences (SPSS) version 20.0. Results: Fourteen patients were found to have S. maltophilia infection during the study period. The majority of patients had respiratory tract infection and bacteraemia. All isolates were from inpatients, more than two-thirds being from the Intensive Care Unit (ICU). A high level of susceptibility was seen to routinely recommended drugs, with 100%, 93% and 79% being susceptible to minocycline, levofloxacin and co-trimoxazole, respectively. All patients (except one) were successfully managed and discharged. Conclusion: S. maltophilia is an emerging opportunistic pathogen and is associated with a plethora of clinical conditions. Early and accurate diagnosis by embracing automation in microbiology laboratories is essential to identify this pathogen. S. maltophilia infections have a favourable outcome when diagnosed and treated timely.
引用
收藏
页码:DC11 / DC15
页数:5
相关论文
共 27 条
  • [1] Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate
    Alsuhaibani, Mohammed
    Aljarbou, Alanoud
    Althawadi, Sahar
    Alsweed, Abdulrahman
    Al-Hajjar, Sami
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2021, 10 (01)
  • [2] Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: A retrospective review and analysis
    Behnia M.
    Logan S.C.
    Fallen L.
    Catalano P.
    [J]. BMC Research Notes, 7 (1)
  • [3] Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
    Biagi, M.
    Vialichka, A.
    Jurkovic, M.
    Wu, T.
    Shajee, A.
    Lee, M.
    Patel, S.
    Mendes, R. E.
    Wenzler, E.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [4] Biswas S, 2020, IRAN J MICROBIOL, V12, P313, DOI 10.18502/ijm.v12i4.3934
  • [5] Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates
    Bostanghadiri, Narjess
    Ardebili, Abdollah
    Ghalavand, Zohreh
    Teymouri, Samane
    Mirzarazi, Mahsa
    Goudarzi, Mehdi
    Ghasemi, Ehsan
    Hashemi, Ali
    [J]. BMC RESEARCH NOTES, 2021, 14 (01)
  • [6] Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
    Brooke, Joanna S.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2012, 25 (01) : 2 - 41
  • [7] Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
    Cho, Sung-Yeon
    Lee, Dong-Gun
    Choi, Su-Mi
    Park, Chulmin
    Chun, Hye-Sun
    Park, Yeon-Joon
    Choi, Jae-Ki
    Lee, Hyo-Jin
    Park, Sun Hee
    Choi, Jung-Hyun
    Yoo, Jin-Hong
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [8] Clinical and Laboratory Standards Institute (CLSI), 2020, CLSI M100
  • [9] Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis
    Colgan, Richard
    Johnson, James R.
    Kuskowski, Michael
    Gupta, Kalpana
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 846 - 851
  • [10] Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
    Denton, M
    Kerr, KG
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) : 57 - +